Skip to content

APOTHEEK DELPLANCKE: what changed

What changed

APOTHEEK DELPLANCKE

BE 0443.834.188
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€140,953
2024 · €128,221+€12,732
Equity
€915,492
2024 · €774,539+€140,953
Cash
€312,705
2024 · €156,996+€155,709
Balance sheet total
€1.1m
2024 · €985,975+€120,309

Largest movements

2024 to 2025
Assets
  • Cash +€155,709

    up €155,709 (+99.2%), from €156,996 to €312,705

    mainly Net result for the year (+€140,953) and Depreciation (+€43,082)

  • Tangible fixed assets -€43,082

    down €43,082 (-9.0%), from €481,181 to €438,099

    of which Land and buildings: -€40,767

  • Receivables within one year +€19,854

    up €19,854 (+10.8%), from €184,641 to €204,495

    of which Other amounts receivable: +€18,801

  • Stocks and contracts -€14,710

    down €14,710 (-9.4%), from €156,546 to €141,836

Equity and liabilities
  • Reserves +€141,041

    up €141,041 (+18.7%), from €755,859 to €896,900

  • Debts after one year -€23,978

    down €23,978 (-28.6%), from €83,744 to €59,766

  • Current portion of long-term debt -€15,944

    down €15,944 (-38.1%), from €41,877 to €25,933

  • Trade debts +€11,879

    up €11,879 (+14.4%), from €82,224 to €94,103

Income statement
  • Gross operating margin +€9,024

    up €9,024 (+3.8%), from €234,391 to €243,415

  • Depreciation -€6,938

    down €6,938 (-13.9%), from €50,020 to €43,082

  • Taxes +€5,356

    up €5,356 (+12.0%), from €44,606 to €49,962

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €128,221
Gross operating margin +€9,024
Depreciation +€6,938
Other operating charges +€538
Financial income +€47
Financial charges +€1,541
Taxes -€5,356
Result 2025 €140,953
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€195,631
Investment €0
Financing -€39,922
Cash 2024 €156,996
Net result for the year +€140,953
Depreciation +€43,082
Stocks and contracts +€14,710
Receivables within one year -€19,854
Deferred charges and accrued income -€2,538
Trade debts +€11,879
Tax, wage and social debts +€414
Other debts +€7,093
Accrued charges and deferred income -€108
Debts after one year -€23,978
Current portion of long-term debt -€15,944
Cash 2025 €312,705
brings cash intakes cash out
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €985,975 €1,106,284 +€120,309 +12.2%
Fixed assets 21/28 €481,181 €438,099 -€43,082 -9.0%
Tangible fixed assets 22/27 €481,181 €438,099 -€43,082 -9.0%
Land and buildings 22 €474,789 €434,022 -€40,767 -8.6%
Plant, machinery and equipment 23 €6,392 €4,077 -€2,315 -36.2%
Current assets 29/58 €504,794 €668,186 +€163,391 +32.4%
Stocks and contracts in progress 3 €156,546 €141,836 -€14,710 -9.4%
Stocks 30/36 €156,546 €141,836 -€14,710 -9.4%
Amounts receivable within one year 40/41 €184,641 €204,495 +€19,854 +10.8%
Trade receivables 40 €104,271 €105,324 +€1,053 +1.0%
Other amounts receivable 41 €80,370 €99,171 +€18,801 +23.4%
Cash at bank and in hand 54/58 €156,996 €312,705 +€155,709 +99.2%
Deferred charges and accrued income 490/1 €6,611 €9,150 +€2,538 +38.4%
Total equity and liabilities 10/49 €985,975 €1,106,284 +€120,309 +12.2%
Equity 10/15 €774,539 €915,492 +€140,953 +18.2%
Contributions 10/11 €18,592 €18,592 = 0.0%
Reserves 13 €755,859 €896,900 +€141,041 +18.7%
Distributable reserves 133 €755,859 €896,900 +€141,041 +18.7%
Profit (loss) carried forward 14 €88 - -€88
Amounts payable 17/49 €211,436 €190,792 -€20,644 -9.8%
Amounts payable after more than one year 17 €83,744 €59,766 -€23,978 -28.6%
Financial debts 170/4 €83,744 €59,766 -€23,978 -28.6%
Amounts payable within one year 42/48 €127,293 €130,735 +€3,442 +2.7%
Current portion of amounts payable after more than one year 42 €41,877 €25,933 -€15,944 -38.1%
Trade debts 44 €82,224 €94,103 +€11,879 +14.4%
Suppliers 440/4 €82,224 €94,103 +€11,879 +14.4%
Taxes, remuneration and social security 45 - €414 +€414
Taxes 450/3 - €414 +€414
Other amounts payable 47/48 €3,191 €10,285 +€7,093 +222%
Accrued charges and deferred income 492/3 €400 €292 -€108 -27.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €50,020 €43,082 -€6,938 -13.9%
Other operating charges 640/8 €7,505 €6,967 -€538 -7.2%
Gross operating margin 9900 €234,391 €243,415 +€9,024 +3.8%
Operating profit (loss) 9901 €176,866 €193,366 +€16,500 +9.3%
Financial income 75/76B €1,800 €1,847 +€47 +2.6%
Recurring financial income 75 €1,800 €1,847 +€47 +2.6%
Financial charges 65/66B €5,839 €4,298 -€1,541 -26.4%
Recurring financial charges 65 €5,839 €4,298 -€1,541 -26.4%
Profit (loss) for the period before taxes 9903 €172,827 €190,915 +€18,087 +10.5%
Income taxes 67/77 €44,606 €49,962 +€5,356 +12.0%
Profit (loss) for the period 9904 €128,221 €140,953 +€12,732 +9.9%
Profit (loss) for the period to be appropriated 9905 €128,221 €140,953 +€12,732 +9.9%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.